R&D Portfolio


CSF Detection

An agreement was reached with Pipeline Biomedical Holdings on May 1, 2007 to develop and commercialize CSF Detect. Click here to see the full press release.

Cerebrospinal fluid (CSF) leaks leading to rhinorrhea or otorrhea are most commonly the result of trauma. Each year in the United States, over 1 million people are treated and released from hospital emergency departments with traumatic head injuries.  An additional 230,000 people are hospitalized with traumatic head injuries each year. Approximately 2-3% of head injuries will result in the occurrence of CSF leaks, making this a relatively common condition seen in hospital emergency rooms. The risk of recurrent meningitis and cerebritis is very high if CSF leaks are not repaired. The concern of physicians missing a CSF leak is very high. The diagnosis of CSF leakage can be difficult, and often requires the patient to be hospitalized until the results from laboratory tests can be examined.

NeuroPro and Pipeline Biomedical Holdings have teamed up to develop and commercialize a rapid test for detecting CSF. Accurate and fast diagnosis will lead to the right treatments being applied sooner and medical dollars being spent more wisely.

Copyright 2006-2011. All rights reserved

NeuroPro Technologies, Inc.